A Repeat Dose Positron Emission Tomography Study With GSK1144814

Summary

This study described in the present protocol consists of two parts. Part A is a multiple ascending dose study to evaluate the safety, tolerability and pharmacokinetics of ascending doses of GSK1144814. Part B is an open label design in healthy male subjects to assess the GSK1144814 Neurokinin1 receptor occupancy.

Timeline

Start

2009-07-01

Primary completion

2009-10-25

Completion

2009-10-25

Drugs

Indications